Cala Health develops the Cala kIQ System, a physician-prescribed wearable that treats hand tremors from essential tremor and Parkinson’s disease using TAPS therapy. TAPS is a non-invasive electrical stimulation of skin nerves delivered via the wearable during roughly 40-minute sessions to reduce tremors. The device collects patient data to help patients and doctors monitor progress and tailor care, blending non-drug therapy with existing medications. It differentiates itself by FDA-approved, physician-prescribed, non-invasive, data-driven therapy that complements medical treatment, with the goal of improving daily tremor management and supporting measurable clinical outcomes.
Company Size
51-200
Company Stage
Growth Equity (Venture Capital)
Total Funding
$298.3M
Headquarters
San Mateo, California
Founded
2014
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?